IVPost
To have or not to have…your left atrial appendage closed
- Details
- Written by Elizabeth Zimmermann
- Category: Health News
Each year in the U.S., more than 300,000 people have heart surgery. To reduce risk of stroke for their patients, surgeons often will close the left atrial appendage, which is a small sac in the left side of the heart where many blood clots form, during these surgeries. Mayo Clinic researchers report today in JAMA that adding this procedure is likely the right choice for certain patients but not all.
Can hypothyroidism cause peripheral neuropathy
- Details
- Written by Todd B. Nippoldt, M.D.
- Category: Health News
Hypothyroidism - a condition in which your thyroid gland doesn't produce enough thyroid hormone - is an uncommon cause of peripheral neuropathy.
Peripheral neuropathy is damage to your peripheral nerves - the nerves that carry information to and from your brain and spinal cord (central nervous system) and the rest of your body, such as your arms and legs.
Mayo Clinic endocrinologist receives career science award from major medical association
- Details
- Written by Caitlin Doran
- Category: Medical News
Sundeep Khosla, M.D, a researcher and physician at Mayo Clinic, has been named the recipient of the 2018 American Association of Clinical Endocrinologists (AACE) Frontiers in Science Award. Considered the AACE’s highest honor, this award, according to the association, “recognizes an individual who has demonstrated exemplary contributions to their profession or area of expertise.”
NIH study finds gut microbiome can control antitumor immune function in liver
- Details
- Written by National Cancer Institute
- Category: Health News
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published online May 24 in Science, was led by researchers in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI). It showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them. NCI is part of the National Institutes of Health.
Study explains why opioid therapy may not always work well for chronic pain
- Details
- Written by National Center for Complementary and Integrative Health
- Category: Health News
Researchers have shown that pain-induced changes in the rat brain’s opioid receptor system may explain the limited effectiveness of opioid therapy in chronic pain and may play a role in the depression that often accompanies it. These findings clearly show the impact of chronic pain on the brain and its relation to depression. The study, conducted by scientists at the National Institutes of Health (NIH) and colleagues from McGill University, Montreal, Quebec, Canada, was published in the journal Pain.
NIH begins testing Ebola treatment in early-stage trial
- Details
- Written by Jennifer Routh
- Category: Latest News
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1 clinical trial is examining the safety and tolerability of a single monoclonal antibody called mAb114, which was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, and their collaborators. Investigators aim to enroll between 18 and 30 healthy volunteers aged 18 to 60. The trial will not expose participants to Ebola virus.
Page 7 of 50